Moreover, anti- and pro-ontogenic properties has been reported for MAPK4 (alias ERK4), thus extending established knowledge about the major role typical MAP kinase pathways ERK1/2-MEK1/2 play in cancer [24]. The gene discussed is MAPK3; the disease is cancer.